Factors predicting intermediate endpoints of cervical cancer and exposure to human papillomavirus (HPV) infections in young women screened as potential targets for prophylactic HPV vaccination in south of Brazil

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 124, Issue 1, 2006, Pages 110-118

  Naud, P ^a   Matos, J ^a   Hammes, L ^a   Stuckzynski, J ^a   Brouwers, K ^a   Magno, V ^a   Dias, E ^a   Crusius, P ^a   D'Avila, A ^a   Campos, C ^a   Costa, M ^a   Hoblik M ^a   Marc, C ^a   Marroni, R ^a   Syrjanen K ^b  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

HPV serology; HPV types; Intermediate endpoints; PAP smear; PCR; Predictive factors; SIL

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; CANCER SCREENING; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 6; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SAMPLE SIZE; SCREENING TEST; SEROPREVALENCE; SEXUALITY; UTERINE CERVIX CARCINOMA; VIRUS DETECTION; VIRUS STRAIN; WART VIRUS;

EID: 29644448314     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2005.02.001     Document Type: Article

References (40)

1. F. Aubin J.L. Pretet C. Mougin Papillomavirus humans. Biologie et Pathologie Tumorale 2003 Editions TEC and DOC Paris 1 759
2. K. Syrjänen, and S. Syrjänen Papillomavirus infections in human pathology 2000 Wiley Chichester pp. 1-615
3. H. Zur Hausen Papillomaviruses and cancer: from basic studies to clinical application Nat Rev Cancer 2 2002 342 350
4. IARC monographs on the evaluation of carcinogenic risks to humans, vol. 64, Papillomaviruses. Lyon: IARC; 1995. p. 1-409.
5. D.M. Parkin S.L. Whelan J. Ferlay L. Raymond J. Young Cancer incidence in five continents vol. VII 1997 IARC Scientific Publications/IARC Press Lyon 142
6. J. Ferlay, F. Bray, P. Pisani, and D.M. Parkin GLOBOCAN 2000: cancer incidence, mortality and prevalence worldwide, Version 1.0, IARC Cancer Base No. 5 2001 IARC Press Lyon
7. P. Naud, A. Camozzato, and L. Hammes Cervical cancer screening in Porto Alegre, Brazil: alternative methods for detecting cancer precursors in a developing country J Lower Gen Tract Dis 5 2001 24 28
8. L.F. Bleggi Torres, B. Werner, and J. Totsugui Cervical cancer screening program of Parana: cost-effective model in a developing country Diagn Cytopathol 29 2003 49 54
9. S.M. Santiago, and G. Andrade Mda Evaluation of a cervical cancer control program in a local health system in southeast Brazil Cad Saude Publica 19 2003 571 578
10. A.B. Miller, S. Nazeer, and S. Fonn Report on consensus conference on cervical cancer screening and management Int J Cancer 86 2000 440 447
11. E. Franco, K. Syrjänen, and C. De-Wolf Proceedings of the Workshop on New Developments in Cervical Cancer Screening and Prevention Geneva, Switzerland, June 17-19, 1996 Cancer Epidemiol Biomarkers Prev 5 1996 853 856
12. N. Munoz, F.X. Bosch, and S. De Sanjose International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer N Engl J Med 6 348 2003 518 527
13. G.M. Clifford, J.S. Smith, M. Plummer, N. Munoz, and S. Franceschi Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis Br J Cancer 88 2003 63 73
14. L. Ho, S.-Y. Chan, and R.D. Burk The genetic drift of human papillomavirus type 16 is a means reconstructing prehistoric viral spread and the movement of ancient human populations J Virol 67 1993 6413 6423
15. L.F. Xi, J.J. Carter, and D.A. Galloway Acquisition and natural history of human papillomavirus type 16 variant infection among a cohort of female university students Cancer Epidemiol Biomarkers Prev 11 2002 343 351
16. C.P. Crum Type-specific testing for human papillomavirus N Engl J Med 349 2003 614 615
17. K. Syrjänen, P. Naud, and S.M. Derchain Comparing PAP smear cytology, aided visual inspection (VIA), screening colposcopy, cervicography and HPV testing by HCII (normal and self-sampling) as optional screening tools in Latin America. Experience from the LAMS study J. Monsonego Proceedings of the 5th International Multidisciplinary Congress EUROGIN 2003, Monduzi Editore, Milano 2003 65 73
18. E.B. Brito, S.J. Martins, and R.C. Menezes Human papillomaviruses in Amerindian women from Brazilian Amazonia Epidemiol Infect 128 2002 485 489
19. S.H. Rabelo-Santos, L. Zeferino, L.L. Villa, J.P. Sobrinho, R.G. Amaral, and A.V. Magalhaes Human papillomavirus prevalence among women with cervical intraepithelial neoplasia III and invasive cervical cancer from Goiania, Brazil Mem Inst Oswaldo Cruz 98 2003 181 184
20. F. Lopes, M.R. Latorre, A.C. Campos Pignatari, and C.M. Buchalla HIV, HPV, and syphilis prevalence in a women's penitentiary in the city of Sao Paulo, 1997-1998 Cad Saude Publica 17 2001 1473 1480
21. D.M. Cerqueira, G.N. Camara, and M.R. Da Cruz Variants of human papillomavirus types 5358 and 66 identified in central Brazil Virus Genes 26 2003 83 87
22. J.E. Levi, B. Kleter, and W.G. Quint High prevalence of human papillomavirus (HPV) infections and high frequency of multiple HPV genotypes in human immunodeficiency virus-infected women in Brazil J Clin Microbiol 40 2002 3341 3345
23. D.A. Galloway Papillomavirus vaccines in clinical trials Lancet Infect Dis 3 2003 469 475
24. A. Billich HPV vaccine MedImmune/Glaxo-Smith-Kline Curr Opin Invest Drugs 4 2003 210 213
25. P. Naud, J. Matos, and L. Hammes HPV prevalence in south of Brazil J. Monsonego Proceedings of the 5th International Multidisciplinary Congress EUROGIN 2003, Monduzi Editore, Milano 2003 193 197
26. Naud P, Matos J, Hammes L, et al. Type-specific prevalence of cervical human papillomavirus infections in southern Brazil, disclosed by screening of potential targets for prophylactic HPV vaccination., submitted for publication.
27. W.G. Quint, G. Scholte, L.J. Van Doorn, B. Kleter, P.H. Smits, and J. Lindeman Comparative analysis of human papillomavirus infections in cervical scrapes and biopsy specimens by general SPF(10) PCR and HPV genotyping J Pathol 194 2001 51 58
28. R.C. Rose, W.I. White, M. Li, J.A. Suzich, C. Lane, and R.L. Garcea Human papillomavirus type 11 recombinant L1 capsomeres induce virus-neutralizing antibodies J Virol 72 1998 6151 6154
29. R. Kirnbauer, N.L. Hubbert, C.M. Wheeler, T.M. Becker, D.R. Lowy, and J.T. Schiller A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16 J Natl Cancer Inst 86 1994 494 499
30. M. Lehtinen, M. Pawlita, and K. Zumbach Evaluation of antibody response to human papillomavirus early proteins in women in whom cervical cancer developed 1 to 20 years later Am J Obstet Gynecol 188 2003 49 55
31. B. Nonnenmacher, J. Pintos, and M.C. Bozzetti Epidemiologic correlates of antibody response to human papillomavirus among women at low risk of cervical cancer Int J STD AIDS 14 2003 258 265
32. M. Hisada, B.J. Van den Berg, and H.D. Strickler Prospective study of antibody to human papilloma virus type 16 and risk of cervical, endometrial, and ovarian cancers (United States) Cancer Causes Contr 12 2001 335 341
33. M.F. Mitchell, W.N. Hittelman, W.K. Hong, R. Lotan, and D. Schottenfeld The natural history of cervical intraepithelial neoplasia: an argument for intermediate endpoint biomarkers Cancer Epidemiol Biomarkers Prev 3 1994 619 626
34. S. Syrjänen, I.P. Shabalova, and N. Petrovichev Human papillomavirus testing and conventional PAP smear cytology as optional screening tools of women at different risk for cervical cancer in countries of former Soviet Union J Lower Genital Tract Dis 6 2002 97 110
35. A.R. Giuliano, R. Harris, and R.L. Sedjo Incidence, prevalence, and clearance of type-specific human papillomavirus infections: the Young Women's Health Study J Infect Dis 186 2002 462 469
36. S. Syrjänen, I.P. Shabalova, and N. Petrovichev Sexual habits and human papillomavirus (HPV) infections among women in three new independent states of the former Soviet Union Sex Transm Dis 30 2003 680 684
37. M. Ciotti, F. Sesti, and P. Paba Human papillomavirus (HPV) testing in the management of women with abnormal Pap smears. Experience of a colposcopy referral clinic Eur J Gynaecol Oncol 25 2004 577 584
38. J.W. Sellors, T.L. Karwalajtys, and J. Kaczorowski Incidence, clearance and predictors of human papillomavirus infection in women CMAJ 168 2003 421 425
39. A.B. Moscicki, S. Shiboski, and J. Broering The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women J Pediatr 132 1998 277 284
40. N.F. Schlecht, S. Kulaga, and J. Robitaille Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia JAMA 286 2001 3106 3114